MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028

Market by Mechanism, Indicator, Consumer, Commodity, and Country Outlook | Forecast 2022-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Based on Triton Market Research’s estimates, the companion diagnostics market in Middle East and Africa is set to witness revenue growth at a CAGR of 12.53% during the forecasted years 2022-2028.



Report scope can be customized per your requirements. Request For Customization 

The countries evaluated in the region comprise:

•         The United Arab Emirates

•        Israel

•         Saudi Arabia

•         Turkey

•         South Africa

•         Rest of Middle East & Africa

Turkey secures the majority of the shares in the Middle East and Africa. In the region, the healthcare demand has soared significantly over the past years. In this regard, a surge in cancer cases and other genetic diseases have compelled governments to invest heavily in the healthcare sector. Additionally, the rising awareness pertaining to genetic screening to help determine drug efficacy is anticipated to encourage manufacturers to develop companion diagnostics devices. Thus, as stated above, these factors are likely to create affluent opportunities for the market.

Turkey’s robust growth can be attributed to the rise in partnerships between government, regulatory agencies, and pharmaceutical companies. Along with this, the implementation of strong laws, economic conditions, and government initiatives are fueling the adoption of companion diagnostics devices. The rising focus on precision medicine is also expected to expand the healthcare sector, elevating the demand for companion diagnostics technology.

In Saudi Arabia, the medical device and in-vitro diagnostics are primarily based on requirements set forth by International Medical Device Regulators Forum and Global Harmonization Task Force. The marketing of these devices is approved by these organizations. Given the guidelines, Biocartis and Amgen collaborated to increase access to RAS biomarker information for metastatic colorectal cancer. Such initiatives create numerous opportunities for the companion diagnostics market.

Companion diagnostics support the precise diagnosis of infectious diseases in humans. Moreover, it helps researchers develop precision medicines for quick treatment and recovery. The infectious disease field includes zoonotic diseases, and vector-borne diseases like smallpox, measles, etc. The market report is segmented into indicator, commodity, mechanism, and consumer. The indicator section is categorized into infectious disease, oncology, neurology, and other indicators.

Almac Group, Biocartis, Danaher Corporation, Genomic Health, Illumina Inc, Myriad Genetics, and Arup Laboratories are among the leading companies in the companion diagnostics market.

Biocartis is a commercial-stage molecular diagnostics company that develops next generation diagnostic solutions. Its product line includes diagnostic tools, advanced analyses, and a technology platform to detect bio-analyses used in various applications. The company has expanded its research and development initiatives in the oncology and infectious disease fields, witnessing a rise in sales. Biocartis serves clients across numerous regions, including the Middle East and Africa.

 

Key deliverables of the report:

·       Market CAGR during the forecasting years 2022-2028

·       Detailed data highlighting key insights, industry components, and market strategies

·     Comprehensive information and estimation of the companion diagnostics market revenue growth in the Middle East and Africa and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·    A wide-ranging study of factors that will challenge the Middle East and Africa companion diagnostics market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COMPANION DIAGNOSTICS MARKET

2.2. KEY INSIGHTS

2.2.1. COMMERCIAL SUCCESS OF PRECISION MEDICINE TREATMENT

2.2.2. ADOPTION OF PREDICTIVE BIOMARKERS

2.2.3. FUSION OF COMPUTER SCIENCE AND BIOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. COST

2.4.2. AVAILABILITY

2.4.3. SENSITIVITY & SPECIFICITY

2.4.4. EFFICACY

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1. ACQUISITIONS

2.9.2. PRODUCT LAUNCHES

2.9.3. CONTRACTS & AGREEMENTS

2.10. MARKET DRIVERS

2.10.1. INCREASE IN INCIDENCE OF MEDICATION REACTIONS

2.10.2. INCREASING PREVALENCE OF CANCER CASES AND FATALITIES

2.10.3. RISING PREVALENCE OF PRECISION MEDICINES

2.11. MARKET CHALLENGES

2.11.1. WEAK REIMBURSEMENT FRAMEWORK

2.11.2. COMMON CASES OF LEAKAGE IN ONCOLOGY COMPANION DIAGNOSTICS

2.12. MARKET OPPORTUNITY

2.12.1. ONGOING RESEARCH AND INVESTMENTS IN NEXT GENERATION GENE-SEQUENCING

3. MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY MECHANISM

3.1. IN-SITU HYBRIDIZATION

3.2. POLYMERASE CHAIN REACTION

3.3. IMMUNOHISTOCHEMISTRY

3.4. NEXT GENERATION SEQUENCING

3.5. OTHER MECHANISMS

4. MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY INDICATOR

4.1. ONCOLOGY

4.2. NEUROLOGY

4.3. INFECTIOUS DISEASES

4.4. OTHER INDICATORS

5. MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY CONSUMER

5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

5.2. REFERENCE LABORATORIES

5.3. OTHER CONSUMERS

6. MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY COMMODITY

6.1. ASSAY KITS AND REAGENTS

6.2. SOFTWARE AND SERVICES

7. MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET - COUNTRY OUTLOOK

7.1. UNITED ARAB EMIRATES

7.2. SAUDI ARABIA

7.3. TURKEY

7.4. SOUTH AFRICA

7.5. REST OF MIDDLE EAST & AFRICA

8. COMPETITIVE LANDSCAPE

8.1. ABBOTT LABORATORIES

8.2. ALMAC GROUP

8.3. ARUP LABORATORIES

8.4. BIOCARTIS

8.5. BIOMERIEUX

8.6. DANAHER CORPORATION

8.7. GE HEALTHCARE

8.8. GENOMIC HEALTH

8.9. ILLUMINA INC

8.10. MYRIAD GENETICS

8.11. QIAGEN

8.12. ROCHE DIAGNOSTICS

8.13. SYSMEX CORPORATION

8.14. THERMO FISHER SCIENTIFIC

8.15. AGILENT

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: LIST OF ACQUISITIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF CONTRACTS & AGREEMENTS

TABLE 6: NUMBER OF CANCER PATIENTS IN 2020

TABLE 7: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)

TABLE 8: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)

TABLE 9: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)

TABLE 10: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)

TABLE 11: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: INDUSTRY COMPONENTS

FIGURE 3: FDA FRAMEWORK

FIGURE 4: CDX LEAKAGE POINTS

FIGURE 5: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2021 & 2028 (IN %)

FIGURE 6: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY IN-SITU HYBRIDIZATION, 2022-2028 (IN $ MILLION)

FIGURE 7: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY POLYMERASE CHAIN REACTION, 2022-2028 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY IMMUNOHISTOCHEMISTRY, 2022-2028 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY NEXT GENERATION SEQUENCING, 2022-2028 (IN $ MILLION)

FIGURE 10: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY OTHER MECHANISMS, 2022-2028 (IN $ MILLION)

FIGURE 11: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2021 & 2028 (IN %)

FIGURE 12: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY ONCOLOGY, 2022-2028 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY NEUROLOGY, 2022-2028 (IN $ MILLION)

FIGURE 14: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2022-2028 (IN $ MILLION)

FIGURE 15: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY OTHER INDICATORS, 2022-2028 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2021 & 2028 (IN %)

FIGURE 17: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 18: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY REFERENCE LABORATORIES, 2022-2028 (IN $ MILLION)

FIGURE 19: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY OTHER CONSUMERS, 2022-2028 (IN $ MILLION)

FIGURE 20: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2021 & 2028 (IN %)

FIGURE 21: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY ASSAY KITS AND REAGENTS, 2022-2028 (IN $ MILLION)

FIGURE 22: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, BY SOFTWARE AND SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 23: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 24: UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

FIGURE 25: SAUDI ARABIA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

FIGURE 26: TURKEY COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

FIGURE 27: SOUTH AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

FIGURE 28: REST OF MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;